Interstitial Lung Disease in Japanese Patients with Lung Cancer-Reference-Cited by-同舟云学术

Interstitial Lung Disease in Japanese Patients with Lung Cancer

Published:2008-06-15 Issue:12 Volume:177 Page:1348-1357
ISSN:1073-449X
Container-title:American Journal of Respiratory and Critical Care Medicine
language:en
Short-container-title:Am J Respir Crit Care Med

Author:

Kudoh Shoji,Kato Harubumi,Nishiwaki Yutaka,Fukuoka Masahiro,Nakata Kouichiro,Ichinose Yukito,Tsuboi Masahiro,Yokota Soichiro,Nakagawa Kazuhiko,Suga Moritaka,Jiang Haiyi,Itoh Yohji,Armour Alison,Watkins Claire,Higenbottam Tim,Nyberg Fredrik,

Publisher

American Thoracic Society

Subject

Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Reference28 articles.

1. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias

2. Severe acute interstitial pneumonia and gefitinib

3. Acute Exacerbation in Idiopathic Pulmonary Fibrosis

4. Wells AU, Hogaboam CM. Update in diffuse parenchymal lung disease 2006.Am J Respir Crit Care Med2007;175:655–660.

5. The epidemiology of interstitial lung disease and its association with lung cancer

Cited by 416 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exposure–response modelling of osimertinib in patients with non‐small cell lung cancer;British Journal of Clinical Pharmacology;2024-08-19

2. Lung Cancer and Interstitial Lung Diseases;Cancers;2024-08-13

3. Interstitial Lung Diseases and Non-Small Cell Lung Cancer: Particularities in Pathogenesis and Expression of Driver Mutations;Genes;2024-07-17

4. The incidence of drug-induced interstitial lung disease caused by epidermal growth factor receptor tyrosine kinase inhibitors or immune checkpoint inhibitors in patients with non-small cell lung cancer in presence and absence of vascular endothelial growth factor inhibitors: a systematic review;Frontiers in Oncology;2024-06-11

5. Japanese guidelines for the treatment of idiopathic pulmonary fibrosis 2023:Revised edition;Respiratory Investigation;2024-05